194 related articles for article (PubMed ID: 25894153)
1. Panel reactive antibodies in predicting hepatitis C virus treatment outcome in kidney transplant candidates.
Öcal S; Harmancı Ö; Korkmaz M; Ensaroğlu F; Çolak T; Selçuk H; Moray G; Haberal M
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():193-6. PubMed ID: 25894153
[TBL] [Abstract][Full Text] [Related]
2. The effect of pretransplant chronic hepatitis C virus infection treatment on graft and patient survival in renal transplant recipients.
Korkmaz M; Fakı S; Öcal S; Harmancı Ö; Ensaroğlu F; Selçuk H; Haberal M
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():188-92. PubMed ID: 25894152
[TBL] [Abstract][Full Text] [Related]
3. Progression of hepatic histopathology in kidney transplant recipients with chronic hepatitis C virus infection and effect of immunosuppression on the course of hepatitis C virus infection.
Korkmaz M; Fakı S; Öcal S; Harmancı Ö; Selçuk H; Haberal M
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():159-64. PubMed ID: 25894147
[TBL] [Abstract][Full Text] [Related]
4. Effect of Single Sensitization Event on Human Leukocyte Antigen Alloimmunization in Kidney Transplant Candidates: A Single-Center Experience.
Resse M; Paolillo R; Pellegrino Minucci B; Costa D; Fiorito C; Santangelo M; De Rosa P; Napoli C
Exp Clin Transplant; 2018 Feb; 16(1):44-49. PubMed ID: 28661314
[TBL] [Abstract][Full Text] [Related]
5. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of interferon for chronic hepatitis C virus-related hepatitis in kidney transplant candidates on hemodialysis: results after transplantation.
Casanovas-Taltavull T; Baliellas C; Benasco C; Serrano TT; Casanova A; Pérez JL; Guerrero L; González MT; Andres E; Gil-Vernet S; Casais LA
Am J Gastroenterol; 2001 Apr; 96(4):1170-7. PubMed ID: 11316166
[TBL] [Abstract][Full Text] [Related]
7. Treatment of hepatitis C virus infection in patients with end-stage renal disease.
Liu CH; Kao JH
J Gastroenterol Hepatol; 2011 Feb; 26(2):228-39. PubMed ID: 21261711
[TBL] [Abstract][Full Text] [Related]
8. Proteinuria among renal transplant patients and its relation to hepatitis C virus and graft outcome: a single center experience.
Sabry A
Exp Clin Transplant; 2010 Jun; 8(2):91-7. PubMed ID: 20565364
[TBL] [Abstract][Full Text] [Related]
9. Treatment of HCV in patients with renal failure.
Kalia H; Lopez PM; Martin P
Arch Med Res; 2007 Aug; 38(6):628-33. PubMed ID: 17613354
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus infection in end-stage renal disease and kidney transplantation.
Burra P; Rodríguez-Castro KI; Marchini F; Bonfante L; Furian L; Ferrarese A; Zanetto A; Germani G; Russo FP; Senzolo M
Transpl Int; 2014 Sep; 27(9):877-91. PubMed ID: 24853721
[TBL] [Abstract][Full Text] [Related]
12. Risk factors of sensitization to human leukocyte antigen in end-stage renal disease patients.
Hung SY; Lin TM; Chang MY; Wang HH; Lee YC; Ho LC; Chen YT; Hung CM; Liou HH
Hum Immunol; 2014 Jun; 75(6):531-5. PubMed ID: 24607727
[TBL] [Abstract][Full Text] [Related]
13. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response.
Chu CM; Sheen IS; Liaw YF
Infection; 2004 Jun; 32(3):153-6. PubMed ID: 15188075
[TBL] [Abstract][Full Text] [Related]
14. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
[TBL] [Abstract][Full Text] [Related]
15. Importance of Liver Biopsy Findings on Prognosis of Kidney Transplant Patients.
Özgün G; Özdemir BH; Tunca MZ; Börcek P; Haberal M
Exp Clin Transplant; 2016 Nov; 14(Suppl 3):37-41. PubMed ID: 27805508
[TBL] [Abstract][Full Text] [Related]
16. Is early virological response as predictive of the hepatitis C treatment response in dialysis patients as in non-uremic patients?
Fucuta Pereira Pda S; Uehara SN; de Mello Perez R; Feldner AC; de Melo IC; de Souza e Silva IS; Silva AE; Ferraz ML
Int J Infect Dis; 2013 Jan; 17(1):e50-3. PubMed ID: 23041364
[TBL] [Abstract][Full Text] [Related]
17. Complete eradication of hepatitis C virus after interferon treatment for chronic hepatitis C.
De Mitri MS; Morsica G; Chen CH; Mele L; Baccarini P; Chianese R; Piccinini A; Lazzarin A; Pisi E
Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):255-61. PubMed ID: 9646218
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome of kidney transplantation in patients with hepatitis C virus infection.
Huo TI; Yang WC; Wu JC; King KL; Lin CY; Loong CC; Lui WY; Chang FY; Lee SD
Hepatogastroenterology; 2001; 48(37):169-73. PubMed ID: 11268958
[TBL] [Abstract][Full Text] [Related]
19. Interferon therapy in hemodialysis patients with chronic hepatitis C virus infection induces a high rate of long-term sustained virological and biochemical response.
Espinosa M; Rodriguez M; Martin-Malo A; Alvarez de Lara MA; Gonzalez R; Lopez-Rubio F; de la Mata M; Aljama P
Clin Nephrol; 2001 Mar; 55(3):220-6. PubMed ID: 11316242
[TBL] [Abstract][Full Text] [Related]
20. Proteinuria after kidney transplantation: its relation to hepatitis C virus and graft outcome.
Sabry A; Hassan R; Mahmoud I; Hamed M; Sobh M
Iran J Kidney Dis; 2007 Oct; 1(2):88-97. PubMed ID: 19363283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
